Biodesix, Inc.
BDSXNASDAQHealthcare● Active
$15.12
+$0.17(+1.14%)
Market Cap$123081018
P/E Ratio—
52W High$20.21
52W Low$5
Biodesix, Inc. (BDSX) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BDSX · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $88.50M | $71.32M | $49.09M | $38.21M | $54.51M |
| Cost of Revenue | $16.72M | $15.57M | $13.01M | $14.15M | $30.52M |
| Gross Profit | $71.78M | $55.75M | $36.08M | $24.06M | $23.99M |
| Gross Margin %(computed) | 81.11% | 78.17% | 73.50% | 62.96% | 44.01% |
| Operating Expenses | |||||
| R&D Expenses | $12.00M | $9.56M | $9.99M | $13.10M | $12.79M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Operating Expenses | $99.55M | $90.25M | $77.42M | $74.64M | $64.93M |
| Operating Income | ($27.77M) | ($34.50M) | ($41.34M) | ($50.59M) | ($40.94M) |
| Operating Margin %(computed) | -31.37% | -48.37% | -84.22% | -132.39% | -75.11% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $7.72M | $8.26M | $9.54M | $8.07M | $4.51M |
| Income Before Tax | ($35.27M) | ($42.93M) | ($52.15M) | ($65.45M) | ($43.16M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($35.27M) | ($42.93M) | ($52.15M) | ($65.45M) | ($43.16M) |
| Net Margin %(computed) | -39.85% | -60.19% | -106.23% | -171.27% | -79.18% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-4.67 | $-6.60 | $-12.80 | $-31.00 | $-31.60 |
| Wtd Avg Shares | 7.55M | 6.48M | 4.11M | 2.11M | 1.37M |
| EBITDA | ($21.95M) | ($29.22M) | ($37.10M) | ($51.53M) | ($35.47M) |
| EBITDA Margin %(computed) | -24.80% | -40.96% | -75.59% | -134.86% | -65.08% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Biodesix, Inc. data
About Biodesix, Inc. (BDSX) Income Statement
Biodesix, Inc. (BDSX) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BDSX reported revenue of $0.09B, gross profit of $0.07B (gross margin 81.11%), and net income of ($0.04B) — a net profit margin of -39.85%.
Frequently asked questions
BDSX · 4 questionsBiodesix, Inc. (BDSX) reported revenue of $0.09B for 2025, up 24.1% year-over-year.
BDSX revenueBDSX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09